Please enable JavaScript.
Coggle requires JavaScript to display documents.
FDA & IA (Fixed Deferred Ann (Pricing considerations (Surplus strain…
FDA & IA
Fixed Deferred Ann
-
-
Pricing considerations
Interest rate risk
rising rates: => higher lapses, lower asset values
-
-
-
-
-
-
-
-
-
Profit metrics
-
Break-even year
-
Ideally, occur before end of Surr Chrg period
-
-
-
-